Bigger checks, fewer seats: reading the 2026 Angel Funders Report

The Angel Capital Association (ACA) has published its 2026 Angel Funders Report. Member angel groups reported $491.3 million invested in 2025, up 12% from $437 million in 2024. That is a recovery number. The part worth reading is the structure of the increase: according to the ACA, the market rose on the back of larger investments per deal.

The difference between ‘more money because there are more deals’ and ‘more money because each deal is bigger’ decides whether a new angel investor can get in at all. The first case opens doors. The second raises the minimum ticket needed to sit at the table.

The recovery came from check size, not from more entry points

The ACA report does not stop at totals. It explicitly flags the concern that as financing rounds grow, angels struggle to keep board influence and strategic oversight. The report also examines valuation trends, financing structures and artificial intelligence investing.

This is the part most coverage skips. When rounds get bigger and a venture capital fund leads, the board seat defaults to the lead. What remains negotiable is information rights, pro-rata rights in later rounds and a board observer seat. These terms are cheap to ask for at the angel round and very expensive to ask for later.

Seed is no longer a single category

Crunchbase data for Q3 2026 sharpens the picture. In Europe, around $2 billion went into more than 750 companies at seed. But the largest seed round was London-based Callosum at $100 million, followed by Munich-based Microagi at $55 million. Those two deals alone account for $155 million of roughly $2 billion. Any average built on that base is distorted.

The global picture is similar. Crunchbase recorded $159 billion in global venture funding in Q3 2026 across close to 6,000 companies — the lowest quarter of 2026 by value. CB Insights reports that average deal size more than doubled and that roughly 80% of Q3 funding came from rounds of $100 million or more. In other words, money concentrates at the top while the majority of companies still fight for oxygen below.

• Averages stop being useful when Europe’s two largest seed rounds together equal nearly 8% of the region’s quarterly seed total.
• Do not use an AI infrastructure seed round as the valuation benchmark for an ordinary software company.
• Larger checks per deal mean a higher threshold for having a voice: the counter is pooling capital through a syndicate or an SPV.
• Price is not the only negotiable term: information rights, pro-rata and an observer seat determine what you can still see after the money moves.

Oversight is the most underpriced term

The real value of angel money is rarely the money. It is having an experienced person close to the company in the first two or three years, before a full management team exists. As average checks grow and institutional funds take the seats, that oversight channel narrows — exactly what the ACA warns about. The practical consequence: the angel’s role shifts from control to access, and whoever fails to write that into the documents loses both.